SR 1001
|
|
|
- CAS-Nr.
- 1335106-03-0
- Englisch Name:
- SR 1001
- Synonyma:
- SR 1001;SR-1001;SR 1001;SR1001 >=98% (HPLC);SR1001, 10 mM in DMSO;SR1001, RORalpha and RORgammat inverse agonist;N-(5-(N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)sulfamoyl)-4-methylthiazol-2-yl)acetamide;N-(5-(N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)sulphamoyl)-4-methylthiazol-2-yl)acetamide;N-(5-{[4-(1,1,1,3,3,3-Hexafluoro-2-hydroxy-2-propanyl)phenyl]sulfamoyl}-4-methyl-1,3-thiazol-2-yl)acetamide;N-[4-Methyl-5-[[[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]amino]sulfonyl]-2-thiazolylacetamide;SR1001,N-{4-Methyl-5-[4-(2,2,2-trifluoro-1-hydroxy-1-trifluoroMethyl-ethyl)-phenylsulfaMoyl]-thiazol-2-yl}-acetaMide
- CBNumber:
- CB52592586
- Summenformel:
- C15H13F6N3O4S2
- Molgewicht:
- 477.4
- MOL-Datei:
- 1335106-03-0.mol
|
SR 1001 Eigenschaften
- Dichte
- 1.640±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,2-8°C
- L?slichkeit
- DMSO: >5mg/mL
- pka
- 5.90±0.50(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to beige
- Stabilit?t:
- Stable for 2 years from date of purchase as supplied. Protect from moisture. Solutions in DMSO may be stored at -20° for up to 3 months.
- InChI
- 1S/C15H13F6N3O4S2/c1-7-11(29-12(22-7)23-8(2)25)30(27,28)24-10-5-3-9(4-6-10)13(26,14(16,17)18)15(19,20)21/h3-6,24,26H,1-2H3,(H,22,23,25)
- InChIKey
- OZBSSKGBKHOLGA-UHFFFAOYSA-N
- SMILES
- CC(=O)Nc1nc(C)c(s1)S(=O)(=O)Nc2ccc(cc2)C(O)(C(F)(F)F)C(F)(F)F
SR 1001 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
SR 1001 is a selective RORc inverse agonist.
SR 1001 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
SR 1001 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 113)Lieferanten
- SR 1001
- SR1001,N-{4-Methyl-5-[4-(2,2,2-trifluoro-1-hydroxy-1-trifluoroMethyl-ethyl)-phenylsulfaMoyl]-thiazol-2-yl}-acetaMide
- N-(5-(N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)sulphamoyl)-4-methylthiazol-2-yl)acetamide
- N-(5-{[4-(1,1,1,3,3,3-Hexafluoro-2-hydroxy-2-propanyl)phenyl]sulfamoyl}-4-methyl-1,3-thiazol-2-yl)acetamide
- N-[4-Methyl-5-[[[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]amino]sulfonyl]-2-thiazolylacetamide
- SR-1001;SR 1001
- Acetamide, N-[4-methyl-5-[[[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]amino]sulfonyl]-2-thiazolyl]-
- SR1001 >=98% (HPLC)
- N-(5-(N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)sulfamoyl)-4-methylthiazol-2-yl)acetamide
- SR1001, RORalpha and RORgammat inverse agonist
- SR1001, 10 mM in DMSO
- 1335106-03-0
- C15H13F6N3O4S2
